Back
Applovin Corp. 10K Form
Sell
40
APP
Applovin Corp.
Last Price:
$376.45
Seasonality Move:
19.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | APP/Applovin Corp. Quarterly |
| 2023-11-08 | 10Q | APP/Applovin Corp. Quarterly |
| 2023-08-09 | 10Q | APP/Applovin Corp. Quarterly |
| 2023-05-10 | 10Q | APP/Applovin Corp. Quarterly |
| 2022-11-10 | 10Q | APP/Applovin Corp. Quarterly |
| 2022-08-12 | 10Q | APP/Applovin Corp. Quarterly |
Receive APP News And Ratings
See the #1 stock for the next 7 days that we like better than APP
APP Financial Statistics
Sales & Book Value
| Annual Sales: | $5.5B |
|---|---|
| Cash Flow: | $1.3B |
| Price / Cash Flow: | 33.88 |
| Annual Sales: | $6.31 |
| Price / Book: | 61.9 |
Profitability
| EPS (TTM): | 9.44520 |
|---|---|
| Net Income (TTM): | $3.3B |
| Gross Margin: | $4.8B |
| Return on Equity: | 255.06% |
| Return on Assets: | 52.73% |
Applovin Corp. Earnings Forecast
Key Applovin Corp. Financial Ratios
-
The Gross Profit Margin over the past 12 years for APP is 87.86%.
-
The Selling, General & Administrative Expenses for APP have been equal to 7.98% of Gross Profit Margin.
-
The Research & Development expenses have been 4.13% of Revenue.
-
The Interest Expense is 6.03% of Operating Income.
-
The Net Earning history of APP is 62.64% of Total Revenues.
-
Per Share Earnings over the last 12 years have been positive in 8 years.
Applovin Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Software |
| Sector: | Information Technology |
| Current Symbol: | APP |
| Website: | applovin.com |
Debt
| Debt-to-Equity Ratio: | 1.66 |
|---|---|
| Current Ratio: | 3.32 |
| Quick Ratio: | 3.23 |
Price-to-Earnings
| Trailing P/E Ratio: | 40.06 |
|---|---|
| Forward P/E Ratio: | 26.48 |
APP Technical Analysis vs Fundamental Analysis
Sell
40
Applovin Corp. (APP)
is a Sell
Is Applovin Corp. a Buy or a Sell?
-
Applovin Corp. stock is rated a SellThe current Applovin Corp. [APP] share price is $390.55. The Score for APP is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.